The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype

Acta Neuropathologica

Volumn 113, Issue 1, 2007, Pages 23-31

  Trembath, Dimitri ^a   Ervin, John F ^b   Broom, Lucy ^b   Szymanski, Mari ^b   Welsh Bohmer, Kathleen ^b   Pieper, Carl ^b   Hulette, Christine M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease (AD); Amyloidbeta (A ); ApoE; Cerebral amyloid angiopathy (CAA); Cerebral arterioles

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGE DISTRIBUTION; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN ARTERY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE DURATION; FEMALE; FRONTAL CORTEX; GENOTYPE; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; OBSERVATIONAL STUDY; PARIETAL LOBE; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; STAINING; TISSUE SECTION; VASCULAR AMYLOIDOSIS; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BLOOD VESSELS; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; POSTMORTEM CHANGES;

EID: 33751204754     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0162-9     Document Type: Article

References (41)

1. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM (1998) Progression of cerebral amyloid angiopathy: Accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 57:353-359
2. Attems J, Jellinger KA (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - a pilot study. Acta Neuropathol (Berl) 107:83-90
3. Attems J, Lintner F, Jellinger KA (2004) Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol (Berl) 107:283-291
4. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368:387-403
5. Bock D (1973) Multivariate statistical methods in behavioral research. McGraw-Hill, New York City
6. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501-1513
7. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259
8. Buee L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM (1994) Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (Berl) 87:469-480
9. Chalmers K, Wilcock GK, Love S (2003) APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Abeta protein. Neuropathol Appl Neurobiol 29:231-238
10. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
11. Coria F, Moreno A, Rubio I, Garcia MA, Morato E, Mayor F Jr (1993) The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals. Neuropathol Appl Neurobiol 19:261-268
12. Coria F, Rubio I (1996) Cerebral amyloid angiopathies. Neuropathol Appl Neurobiol 22:216-227
13. DeMattos RB (2004) Apolipoprotein E dose-dependent modulation of beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci 23:255-262
14. Ellison D, Love S (2004) Neuropathology: A reference text of CNS pathology. Mosby Edinburgh, New York
15. Ervin JF, Pannell C, Szymanski M, Welsh-Bohmer K, Schmechel DE, Hulette CM (2004) Vascular smooth muscle actin is reduced in Alzheimer disease brain: A quantitative analysis. J Neuropathol Exp Neurol 63:735-741
16. Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM (2005) Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci 25:2803-2810
17. German DC, Eisch AJ (2004) Mouse models of Alzheimer's disease: Insight into treatment. Rev Neurosci 15:353-369
18. Hulette CM, Ervin JF, Pannell C, Schmechel DE, Strittmatter WJ, Sanders AM (2001) Vascular pathology in Alzheimer's disease. Neurology 56:A182
19. Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM (1998) Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57:1168-1174
20. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095-1097
21. Koudinova NV, Berezov TT, Koudinov AR (1999) Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses. Biochemistry (Mosc) 64:752-757
22. Mahley RW (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630
23. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
24. Nicoll JA, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV (1997) High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41:716-721
25. Nussbaum RL, Ellis CE (2003) Alzheimer's disease and Parkinson's disease. N Engl J Med 348:1356-1364
26. Olichney JM, Hansen LA, Hofstetter CR, Lee J-H, Katzman R, Thal LJ (2000) Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein e4. Arch Neurol 57:869-874
27. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN (1996) Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 148:2083-2095
28. Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO (2003) Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: Defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 29:106-117
29. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575-580
30. Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53:429-437
31. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
32. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649-9653
33. Stoll G, Meuller HW, Trapp BD, Griffin JW (1989) Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. Glia 2:170-176
34. Thal DR, Ghebremedhin E, R̈b U, Yamaguchi H, Del Tredici K, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:282-293
35. Thal DR, Ghebremedhin E, Orantes M, Wiestler OD (2003) Vascular pathology in Alzheimer disease: Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287-1301
36. Tian J, Shi J, Bailey K, Lendon CL, Pickering-Brown SM, Mann DM (2004) Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75:696-699
37. Tian J, Shi J, Smallman R, Iwatsubo T, Mann DM (2006) Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Appl Neurobiol 32:332-340
38. Vinters HV (1987) Cerebral amyloid angiopathy. Acritical review. Stroke 18:311-324
39. Yamada M (2004) Cerebral amyloid angiopathy and gene polymorphisms. J Neurol Sci 226:41-44
40. Zarow C, Zaias B, Lyness SA, Chui H (1999) Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss. Alzheimer Dis Assoc Disord 13:1-8
41. Zhang WW, Lempessi H, Olsson Y (1998) Amyloid angiopathy of the human brain: Immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Acta Neuropathol (Berl) 96:558-563